Home JournalsJournal Details
ISSN: 1540-1405 eISSN: 1540-1413 CAS Zone: Medicine (Zone 2) Emerging Zone: Medicine (Zone 2) No

Journal of the National Comprehensive Cancer Network

Abbr. J NATL COMPR CANC NE ·UNITED STATES ·Frequency Monthly ·Avg. articles/yr 129 articles
17.5
Latest IF
1.30%
Self-citation
Submission difficulty
偏慢,4 - 8周
Review cycle
About Journal

The Journal of the National Comprehensive Cancer Network (JNCCN), identified by ISSN 1540-1405, is a highly respected monthly publication based in the United States and issued by the National Comprehensive Cancer Network (NCCN). As a non-open access journal indexed in the Science Citation Index (SCI), it holds a prominent position in the medical field, ranking in the first quartile of the Chinese Academy of Sciences journal classification and maintaining a strong 2022 impact factor of 12.693. The journal serves as a critical resource for the global oncology community by disseminating authoritative clinical practice guidelines, original research, reviews, and commentary that focus on the diagnosis, treatment, and prevention of cancer. With a strong emphasis on multidisciplinary integrated care and evidence-based medicine, JNCCN provides clinicians with practical, up-to-date recommendations designed to directly inform patient management. While its close affiliation with the NCCN ensures high academic influence and utility, readers are advised to consider the journal’s primary focus on U.S. clinical practices when applying its findings, potentially necessitating cross-referencing with local guidelines to ensure optimal international applicability.

Recent Articles
2026-09-23
Targeting KRAS-Mutant Lung Cancers
Garbo E, Scaparone P, Hoe H et al · 1-8
2026-09-18
2026-09-16
B-Cell Lymphomas, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
Zelenetz A, Gordon L, Abramson J et al · Vol 24(9)
2026-09-16
New Paradigms in the Management of Castleman Disease
Nishimura Y, Habermann T, Noy A · Vol 24(9)
2026-09-01
2026-07-14
Journal Info
ISSN
1540-1405
Abbr.
J NATL COMPR CANC NE
Region
UNITED STATES
Frequency
Monthly
CAS Zone
Medicine (Zone 2) · Non-Top
Emerging Zone
Medicine (Zone 2) · Non-Top
Open Access
No
Research Area
ONCOLOGY -
Coverage
Science Citation Index Expanded
Sub-categories
ONCOLOGYZone 3
Emerging Categories
ONCOLOGYZone 2
Submission & Homepage
Submit Homepage
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com